CSF1R inhibitors mitigate CDK4/6 inhibitor-induced immunosuppression to increase antitumor immunity in HR+/HER2- breast cancer.

Saved in:
Bibliographic Details
Title: CSF1R inhibitors mitigate CDK4/6 inhibitor-induced immunosuppression to increase antitumor immunity in HR+/HER2- breast cancer.
Authors: Li S; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Gong Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Li H; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Liu S; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Yin Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Yu Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Chu Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Hou J; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Liu J; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Zhang H; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Nanding A; Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China., Yuan W; Institute of Cancer Prevention and Treatment, Harbin Medical University, Harbin, China.; Institute of Cancer Prevention and Treatment, Heilongjiang Academy of Medical Sciences, Harbin, China., Zhang Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China., Wang Q; Department of Scientific Research, Harbin Medical University Cancer Hospital, Harbin, China., Wu H; Sino-Russian Medical Research Center, Harbin Medical University Cancer Hospital, Harbin, China., Zhang X; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China. zhangxianyu@ems.hrbmu.edu.cn., Pang D; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China. pangda@ems.hrbmu.edu.cn.
Source: Oncogene [Oncogene] 2026 Jun; Vol. 45 (21), pp. 1970-1987. Date of Electronic Publication: 2026 Apr 15.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5594
DOI:10.1038/s41388-026-03786-w